Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Sirtuin 1 (SIRT1) mRNA 3' untranslated region (3' UTR) is a critical regulatory segment of the SIRT1 transcript that governs the post-transcriptional expression of the SIRT1 protein. SIRT1 is a nicotinamide adenine dinucleotide (NAD+)-dependent deacetylase involved in various cellular processes, including DNA repair, metabolism, and longevity (Yamakuchi, 2012, PMID: 22595653). The 3' UTR contains binding sites for numerous microRNAs (miRNAs), such as miR-34a, miR-132, and miR-217, as well as RNA-binding proteins like HuR (ELAVL1), which collectively modulate mRNA stability and translation efficiency (Abdelmohsen et al., 2007, PMID: 17471022). In many age-related and metabolic diseases, SIRT1 expression is downregulated due to the overexpression of inhibitory miRNAs targeting this region (Choi et al., 2013, PMID: 23434671). Consequently, the SIRT1 mRNA 3' UTR has emerged as a therapeutic target for antisense oligonucleotides (ASOs) and miRNA modulators aimed at restoring SIRT1 levels to treat conditions like type 2 diabetes and neurodegeneration. Conversely, in certain cancers where SIRT1 promotes tumor survival, targeting this region with miRNA mimics like MRX34 to decrease SIRT1 expression has been explored, though clinical applications have faced challenges regarding systemic toxicity (Beg et al., 2017, PMID: 28115468).
Modulation of SIRT1 protein expression by altering mRNA stability or inhibiting/promoting translation through competitive binding at the 3' untranslated region.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sirtuin 1 mRNA 3' untranslated region (SIRT1 mRNA 3' UTR) (SIRT1 mRNA 3' UTR).